Your browser doesn't support javascript.
loading
Barriers to Receiving Follow-up Care Among Childhood Cancer Survivors.
Bossert, Sharon; Borenzweig, William; Benedict, Catherine; Cerise, Jane E; Siembida, Elizabeth J; Fish, Jonathan D.
Afiliação
  • Bossert S; Zucker School of Medicine at Hofstra/Northwell, Hempstead.
  • Borenzweig W; Zucker School of Medicine at Hofstra/Northwell, Hempstead.
  • Benedict C; Stanford University School of Medicine, Stanford, CA.
  • Cerise JE; Feinstein Institute for Medical Research.
  • Siembida EJ; Feinstein Institute for Medical Research.
  • Fish JD; Institute of Health System Science, Northwell Health, Manhasset, NY.
J Pediatr Hematol Oncol ; 45(7): e827-e832, 2023 10 01.
Article em En | MEDLINE | ID: mdl-37526350
ABSTRACT
Little is known on why adherence to follow-up care in childhood cancer survivors (CCS) is lacking. This study characterized barriers to adherence to follow-up care among CCS, identified sociodemographic correlates of barriers, and examined whether barriers to follow-up care relate to health-related quality of life. Adult CCS (N=84) were anonymously surveyed via REDCap using the Barriers to Care Questionnaire (BCQ) and the Quality of Life Scale-Cancer Survivor (QOL-CS). Both descriptive and correlation analyses were conducted. The median BCQ total score was 88.5 (interquartile ranges78.4 to 95.7), with the greatest barriers reported in the Skills (eg, ease of navigating the healthcare system) and Pragmatism subscales (eg, cost). There was a statistically significant correlation between the BCQ total score and the QOL-CS total score (rs=0.47, P <0.0001) and the physical, psychological, and social QOL-CS subscales (all P 's<0.05). The results found that barriers to follow-up care for CCS are mostly related to cost and appointment logistics, and that more barriers to care is associated with lower health-related quality of life among CCS. Identifying barriers to follow-up care is the first step in improving adherence, which would allow for earlier detection of late effects of cancer therapy and thereby result in reductions in morbidity and mortality.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Child / Humans Idioma: En Revista: J Pediatr Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Child / Humans Idioma: En Revista: J Pediatr Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2023 Tipo de documento: Article